Mega Contracts Monitor ($100M+) — January 16, 2026

Four contracts worth $6.9B+ to Northrop, Boeing, L3Harris, Lockheed for propulsion/spacecraft/R&D extend to 2048, with $784M-$958M outlays signaling execution.

GSA/VA/Ed/SSA awards totaling $4B+ to Accenture, CACI, Booz Allen, GDIT, ECS, Manhattan provide multi-year IT/telecom/intel support, with 70%+ outlays in mature deals.

$2.3B in CMS construction/file services to Novitas, Hensel Phelps, GDIT through 2029, with 45-60% outlays indicating steady cash flow.

Ultra-long performance periods (24-35 years in L3Harris/Lockheed) expose to program cuts/delays; low/zero outlays in 5 contracts (e.g., ECS $0 on $99M) flag ramp risks.

Subawards dominate (97% in Booz Allen, $294M>obligation in GDIT, 136 in AAR), risking margins/dependencies.

Cost-plus/FFP structures in 11/13 contracts shift overrun risk to firms; negative outlay (-$1.2M CACI) signals billing disputes.

$5B+ unexercised options (e.g., $2.3B Lockheed, $2.4B CACI, $0.5B ECS) across 12 contracts for phased revenue unlock.

Extensions to 2028-2048 in 8 contracts (e.g., Novitas to 2028, Lockheed to 2048) amid Title IV/EHRM/SLS continuity.

Small biz win (Manhattan $132M SSA telecom to 2032 potential) undervalued vs. primes; full options $272M.

53% of value ($6.9B) in non-competed/long-term NASA deals for propulsion/spacecraft, outlays $1.9B+ signaling commitment.

40% value in competed IT/health contracts with 50%+ avg outlays, heavy sub use but steady execution.

{"entity"=>"Lockheed Martin (NASA GEOXO)", "reason"=>"$2.3B options on $263M base amid 24yr term; highest upside potential.", "trigger"=>"Option exercise >$500M triggers buy"}

{"entity"=>"CACI (GSA JIDA)", "reason"=>"$1.5B+ options despite negative outlay flag; intel analysis scalability.", "trigger"=>"Outlay reversal + intel budget hike"}

{"entity"=>"NASA SLS/Propulsion Programs", "reason"=>"Multi-firm $7B+ exposure (Northrop/Boeing); funding shifts critical.", "trigger"=>"Budget cuts -> trim space overweight"}